DefinePK hosts the largest index of Pakistani journals, research articles, news headlines, and videos. It also offers chapter-level book search.
Title: Effectiveness of Non-Invasive vs. Invasive Ventilation in Acute Hypoxic Respiratory Failure in COVID-19 Patients in Critical Care: A Retrospective Cohort in Rahim Yar Khan, Pakistan
Authors: Sairah Sadaf, Haq Dad Durrani, Babar Bashir
Journal: Pakistan Journal of Medical Research (PJMR)
Publisher: Health Research Institute (HRI), NIH
Country: Pakistan
Year: 2021
Volume: 60
Issue: 2
Language: English
Keywords: COVID-19Non-invasive ventilationCritical Careacute Hypoxic repiratory failure
Background: Acute hypoxic respiratory failure (AHRF) is the most common reason of ICU admissions. Invasive (IV) and non-invasive ventilation (NIV) methods are incorporated in ICUs as part of initial treatment.
Objective: To compare the outcomes of COVID-19 patients with acute hypoxic respiratory failure on non-invasive and invasive ventilation.
Study type, settings & duration: This retrospective cohort study was conducted at Intensive Care Unit, Sheikh Zayed Medical College/Hospital, Rahim Yar Khan from March to August 2020.
Methodology: The 72 COVID-19 positive patients, placed in two groups “IV” (invasive ventilation) and “NIV” (non-invasive ventilation) as per treatment they received in ICU. Outcome was defined in terms of patient’s survival and number of complications associated with both modes of ventilation.
Results: More patients showed survival on NIV than on IV (36.6 % vs. 6.4% respectively) with a significant p =0.003. Number of complications was low in NIV group vs. IV group. Males were more affected than females (83.3% vs. 16.7%). Middle and old aged groups were more prone to develop severe hypoxia and required ICU admission as compared to young people (47.2% vs. 37.5% vs. 15.3%) respectively with p=0.017, reflecting better survival in younger people.
Conclusion: NIV should be prioritized in ICUs for early management of acute hypoxic respiratory failure associated with COVID-19 as NIV has negligible adverse affects and better outcome than IV.
Loading PDF...
Loading Statistics...